Continuum Advisory’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Continuum Advisory's BMY Position: Q2 2026 in Review
Continuum Advisory opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 5,810 shares worth $335K. The stake represents 0.03% of the portfolio and ranks #367 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in BMY as recently as Q1 2025.
Continuum Advisory first reported a position in BMY in Q2 2021 and has held it in 7 quarters since. The position peaked at $2.81M in Q1 2024. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Continuum Advisory held 5,810 shares of Bristol-Myers Squibb worth $335K as of Q2 2026.
- Bristol-Myers Squibb was a new Continuum Advisory position in Q2 2026.
- Bristol-Myers Squibb made up 0.03% of Continuum Advisory's portfolio in Q2 2026, its #367 holding.
- Continuum Advisory first reported a position in Bristol-Myers Squibb in Q2 2021 and has held it in 7 quarters since.
- Continuum Advisory's Bristol-Myers Squibb position peaked at $2.81M in Q1 2024.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.